Medical management of intermittent claudication

Kevin Casey1, Britt H Tonnessen, W Charles Sternbergh

  • 1Department of Vascular Surgery, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.

Insights

Intermittent claudication (IC) symptoms often prompt medical visits, but few cases progress to severe outcomes. Managing co-morbidities and risk factors is crucial for these patients.

Area of Science:

  • Vascular Medicine
  • Cardiology
  • Peripheral Artery Disease

Background:

  • Intermittent claudication (IC) is a common symptom prompting medical evaluation.
  • A minority of patients with IC experience limb-threatening ischemia or severe lifestyle limitations.
  • Patients with IC have a high prevalence of concurrent cardiovascular and cerebrovascular diseases.

Purpose of the Study:

  • To review the clinical presentation and management of intermittent claudication.
  • To highlight the importance of assessing and managing co-morbidities in IC patients.
  • To discuss the role of pharmacotherapy in alleviating IC symptoms.

Main Methods:

  • Literature review of studies on intermittent claudication.
  • Analysis of risk factors and co-morbidities associated with IC.
  • Evaluation of pharmacological interventions for IC symptom management.

Main Results:

  • Most IC cases do not progress to severe limb ischemia.
  • Cardiovascular and cerebrovascular disease assessment and risk factor control are vital.
  • While no single drug cures IC, some therapies can reduce symptoms as adjuvant treatment.

Conclusions:

  • Intermittent claudication management requires a comprehensive approach.
  • Addressing co-morbidities significantly mitigates cardiovascular risk in IC patients.
  • Pharmacological agents can serve as valuable adjuncts for symptom relief in IC.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...